Skip to main content
Log in

Iron deficiency suppresses ileal nitric oxide synthase activity

  • Published:
Journal of Gastrointestinal Surgery

Abstract

Intestinal motility disorders are more common in women of childbearing age who are prone to iron deficiency anemia. The neurotransmitters nitric oxide (NO) and acetylcholine (ACh) play a key role in ileal smooth muscle relaxation and contraction, respectively. Iron-containing heme is known to be a cofactor for nitric oxide synthase (NOS), the enzyme responsible for NO production. Therefore we tested the hypothesis that iron deficiency would downregulate ileal NOS activity without affecting the ileum’s response to ACh. Twelve adult female prairie dogs were fed either an ironsupplemented (Fe+) (200 ppm) (n = 6) or an iron-deficient (Fe-) (8 ppm) (n = 6) diet for 8 weeks. Ileal circular muscle strips were harvested to measure responses to ACh and electrical field stimulation. Under nonadrenergic noncholinergic (NANC) conditions, Nω-nitro-L-arginine (L-NNA), an NOS inhibitor, and VIP10-28, a vasoactive intestinal peptide (VIP) inhibitor, were added prior to electrical field stimulation. NANC inhibitory responses are expressed as a percentage of optimal relaxation from EDTA. The excitatory response to ACh was similar in both groups (1.1 ± 0.3 N/cm2 vs. 1.5 ± 0.3 N/cm2, P = 0.45). The inhibitory response to electrical field stimulation under NANC conditions was greater in the Fe+ group (34.7 ±2.9%) compared to the Fe-group (23.9 ±3.2%; P <0.01). L-NNA eliminated the inhibitory response in the Fe+ group (0.02 ± 0.02%) but not in the Fe-group (8.38 2 2.15%; P <O.Ol). VIP10-28 led to greater relaxation in the Fe+ animals (45.8 ± 6.6%) than in the Fe-animals (23.4 ±5.8%; P <0.05). Both L-NNA and VIP10-28 had no inhibitory response (0.02 ± 0.02%) in the Fe+ animals, whereas the Fe-animals had some residual inhibition (2.54 ±1.04%; P <0.05). These data suggest that ileal NANC relaxation is due to NOS and that iron deficiency results in (1) decreased NANC relaxation, (2) a compensatory relaxation due to a non-NOS, non-VIP mechanism, and (3) a normal excitatory response. We conclude that iron deficiency suppresses ileal NOS activity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Toner BB, Akman D. Gender role and irritable bowel syndrome: Literature review and hypothesis. Am J Gastroenterol 2000;95:11–16.

    Article  PubMed  CAS  Google Scholar 

  2. Kellow JE, Phillips SF, Miller LJ, Zinmeister AR. Dysmotility of the small intestine in irritable bowel syndrome. Gut 1988;29:1236–1243.

    Article  PubMed  CAS  Google Scholar 

  3. Klatt P, Pfeiffer S, List BM, Lehner D, Glatter O, Bachinger HP, Werner ER, Schmidt K, Mayer B. Characterization of heme-deficient neuronal nitric-oxide synthase reveals a role for heme in subunit dimerization and binding of the amino acid substrate tetrahydrobiopterin. J Biol Chem 1996;271:7336–7342.

    Article  PubMed  CAS  Google Scholar 

  4. Swarm-Basile DA, Goldblatt MI, Blaser C, Decker PA, Ahrendt SA, Sama SK, Pitt HA. Iron deficiency diminishes gallbladder neuronal nitric oxide synthase. J Surg Res 2000;90:26–31.

    Article  Google Scholar 

  5. Looker AC, Dallman PR, Carroll MD, Gunter EW, Johnson CL. Prevalence of iron deficiency anemia in the United States. JAMA 1997;277:973–976.

    Article  PubMed  CAS  Google Scholar 

  6. Van Der Lainden W. Some biological traits of female gallstone disease patients. Acta Chir Stand Suppl 1961;269:l-94.

    Google Scholar 

  7. Johnston SM, Lipsett PA, Fox-Talbot MK, Lillemoe KD, Pitt HA. Transferrin is a potent cholesterol crystal nucleator. Hepatology 1995;16:110A.

    Google Scholar 

  8. Johnston SM, Murray KP, Martin SA, Fox-Talbot MK, Lipsett PA, Lillemoe KD, Pitt HA. Iron deficiency enhances cholesterol gallstone formation. Surgery 1997;122:354–362.

    Article  PubMed  CAS  Google Scholar 

  9. Murray KP, Shin JH, Fox-Talbot MK, Johnston SM, Lipsett PA, Lillemoe KD, Pitt HA. Iron deficiency inhibits gallbladder motility [abstr]. Gastroenterology 1998;114:A1412.

    Article  Google Scholar 

  10. Murray KP, Kaufman HS, Fox-Talbot MK, Lillemoe KD, Pitt HA. Iron deficiency alters sphincter of Oddi motility. J Surg Res (in press).

  11. Li CG, Rand MJ. Nitric oxide and vasoactive intestinal polypeptide mediate non-adrenergic, non-chohnergic inhibitory transmission to smooth muscle in rat gastric fundus. Eur J Pharmacol 1990;191:303–309.

    Article  PubMed  CAS  Google Scholar 

  12. Murray J, Du C, Ledlow A, Bates JN, Conklin JL. Nitric oxide: Mediator of non-adrenergic, non-cholinergic responses of opossum esophageal muscle. Am J Physiol 1991;261:G401-G406.

    PubMed  CAS  Google Scholar 

  13. Masimo H, Goyal RK. Lessons from genetically engineered animal models IV Nitric oxide synthase gene knockout mice. AmJ Physiol 1999;277:G745-G750.

    Google Scholar 

  14. Stuehr DJ. Mammalian nitric oxide synthases. Biochim Biophys Acta 1999;1411:217–230.

    Article  PubMed  CAS  Google Scholar 

  15. Dick JM, Lefebvre RA. Influence of different classes of NO synthase inhibitors in the pig gastric fundus. Naunyn Schmiedebergs Arch Pharmacol 1997;356:488–494.

    Article  PubMed  CAS  Google Scholar 

  16. Furfine ES, Harmon MF, Paith JE, Garvey EP. Selective inhibition of constitutive nitric oxide synthase by L-NG-nitroarginine. Biochemistry 1993;32:8512–8517.

    Article  PubMed  CAS  Google Scholar 

  17. Glasgow I, Mattar K, Krantis A. Rat gastroduodenal motility in vivo: Involvement of NO and ATP in spontaneous motor activity. Am J Physiol 1998;275:G889-G896.

    PubMed  CAS  Google Scholar 

  18. Grider JR, Murthy KS, Jin JG, Makhlouf GM. Stimulation of nitric oxide from muscle cells by VIP: Prejunctional enhancement of VIP release. AmJ Physiol 1992;262:G774-G778.

    CAS  Google Scholar 

  19. Ekblad E, Sundler F. Motor responses in rat ileum evoked by nitric oxide donors vs. field stimulation: Modulation by pituitary adenylate cyclase-activating peptide, forskolin and guanylate cyclase inhibitors. J Pharmacol Exp Ther 1997;283:23–28.

    PubMed  CAS  Google Scholar 

  20. Yagasaki O, Nabata H, Yanagiya I. Effects of desensitization to adenosine 5’-triphosphate and vasoactive intestinal polypeptide on non-adrenergic inhibitory responses of longitudinal and circular muscles in the rat ileum. J Pharm Pharmacol 1983;35:818–820.

    PubMed  CAS  Google Scholar 

  21. D’Amato M, De Beurme FA, Lefebvre RA. Comparison of the effect of vasoactive intestinal polypeptide and non-adrenergic non-cholinergic neurone stimulation in the cat gastric fundus. Eur J Pharmacol 1988;152:71–82.

    Article  PubMed  CAS  Google Scholar 

  22. Grider JR, Rivier JR. Vasoactive intestinal peptide (VIP) as transmitter of inhibitory motor neurons of the gut: Evidence from the use of selective VIP antagonists and VIP antiserum. J Pharmacol Exp Ther 1990;253:738–742.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Supported by grant ROI-DK44279-07 from the National Institutes of Health.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Goldblatt, M.I., Choi, SH., Basile, D.A.S. et al. Iron deficiency suppresses ileal nitric oxide synthase activity. J Gastrointest Surg 5, 393–400 (2001). https://doi.org/10.1016/S1091-255X(01)80068-8

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1016/S1091-255X(01)80068-8

Key words

Navigation